1. Home
  2. PRPL vs IMUX Comparison

PRPL vs IMUX Comparison

Compare PRPL & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Innovation Inc.

PRPL

Purple Innovation Inc.

HOLD

Current Price

$0.72

Market Cap

89.8M

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$0.51

Market Cap

85.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPL
IMUX
Founded
2010
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.8M
85.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRPL
IMUX
Price
$0.72
$0.51
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$1.00
$6.00
AVG Volume (30 Days)
225.0K
1.5M
Earning Date
11-04-2025
02-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$457,012,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$0.52
52 Week High
$1.29
$1.39

Technical Indicators

Market Signals
Indicator
PRPL
IMUX
Relative Strength Index (RSI) 42.89 29.05
Support Level $0.70 $0.55
Resistance Level $0.78 $0.60
Average True Range (ATR) 0.04 0.04
MACD -0.01 -0.01
Stochastic Oscillator 17.73 2.01

Price Performance

Historical Comparison
PRPL
IMUX

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: